BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 2015;21:1020-6. [PMID: 26163105 DOI: 10.1016/j.cmi.2015.06.028] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Toka B, Eminler AT, Gönüllü E, Tozlu M, Uslan MI, Parlak E, Karabay O, Koksal AS. Rheumatologists’ awareness of hepatitis B reactivation before immunosuppressive therapy. Rheumatol Int 2019;39:2077-85. [DOI: 10.1007/s00296-019-04437-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Akdemir Kalkan I, Karasahin O, Sarigul F, Altunisik Toplu S, Aladag M, Akgul F, Mete AO, Golbol A, Nazik S, Kömür S, Merve Oren M, Yildiz Y, Demir Y, Ayhan M, Tasova Y, Bayındır Y, Dal T, Celen MK. Comparison of Tenofovir Alafenamide and Entecavir Therapy in Patients with Chronic Hepatitis B Initially Treated with Tenofovir Disoproxil: A Retrospective Observational Survey. Hepat Mon 2022;21. [DOI: 10.5812/hepatmon.118721] [Reference Citation Analysis]
3 Asan A, Sayan M, Akhan S, Tekin Koruk S, Aygen B, Sirmatel F, Eraksoy H, Tuna N, Köse S, Kaya A, Eren Tulek N, Aktug Demir N, Mistik R, Ormen B, Korkmaz F, Yildirmak T, Ural O, Aydin M, Turgut H, Gunal O, Demirturk N. Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.12472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Idilman R, Akyildiz M, Keskin O, Gungor G, Yilmaz TU, Kalkan C, Dayangac M, Cinar K, Balci D, Hazinedaroglu S, Tokat Y. The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence. Clin Transplant. 2016;30:1216-1221. [PMID: 27409074 DOI: 10.1111/ctr.12804] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
5 Düzenli T, Köseoğlu H. Physician awareness of hepatitis C virus among different departments. Clin Exp Hepatol 2020;6:354-8. [PMID: 33511284 DOI: 10.5114/ceh.2020.102155] [Reference Citation Analysis]
6 Onerci Celebi O, Araz Server E, Hamit B, Yiğit Ö. The seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus in patients undergoing septoplasty. Braz J Otorhinolaryngol 2016:S1808-8694(16)30227-0. [PMID: 27932200 DOI: 10.1016/j.bjorl.2016.10.008] [Reference Citation Analysis]
7 Yozgat A, Can G, Can H, Ekmen N, Akyol T, Kasapoglu B, Kekilli M. Social stigmatization in Turkish patients with chronic hepatitis B and C. Gastroenterol Hepatol 2021;44:330-6. [PMID: 33213938 DOI: 10.1016/j.gastrohep.2020.08.008] [Reference Citation Analysis]
8 Omar HH. Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives. Hepat Med 2019;11:131-6. [PMID: 31565002 DOI: 10.2147/HMER.S155962] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
9 Gokcan H, Idilman R. Hepatitis D Infection in Asia: A Perspective From an Endemic Region. Clin Liver Dis (Hoboken) 2021;18:26-9. [PMID: 34484701 DOI: 10.1002/cld.1106] [Reference Citation Analysis]
10 Bilman FB, Tosun S, Yildiz IE, Alay H, Evrenos AN, Kutlu HH, Cakar ZS, Kesli R, Altuntas SB, Altuntas B. Prevalence of HBsAg seropositivity during pregnancy and evaluation of vaccination programs: A multicenter study in Turkey. North Clin Istanb 2021;8:359-64. [PMID: 34585070 DOI: 10.14744/nci.2020.26504] [Reference Citation Analysis]
11 Akkuzu MZ, Sezgin O, Yaraş S, Özdoğan O, Yılmaz İ, Üçbilek E, Ateş F, Altıntaş E. Patients Lost after Anti-HCV-Positive Finding in a Tertiary Care University Hospital: Increased Awareness and Action is Necessary to Eradicate HCV. Sisli Etfal Hastan Tip Bul 2019;53:366-70. [PMID: 32377110 DOI: 10.14744/SEMB.2019.46656] [Reference Citation Analysis]
12 Ekin N, Ucmak F, Atay AE. Evaluation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Reference Center Hospital in Turkey's Southeast Anatolia Among Patients Referred for Major or Minimally Invasive Surgery: Last Decade Experience in a Previously High Prevalence Area. Jundishapur J Microbiol 2021;14. [DOI: 10.5812/jjm.119654] [Reference Citation Analysis]
13 Özkan H. Epidemiology of Chronic Hepatitis B in Turkey. Euroasian J Hepatogastroenterol 2018;8:73-4. [PMID: 29963468 DOI: 10.5005/jp-journals-10018-1264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Idilman R, Razavi H, Robbins-Scott S, Akarca US, Örmeci N, Kaymakoglu S, Aygen B, Tozun N, Güner R, Bodur H, Lazarus JV. A micro-elimination approach to addressing hepatitis C in Turkey. BMC Health Serv Res 2020;20:249. [PMID: 32209103 DOI: 10.1186/s12913-020-5019-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Barut S, Gemici Ü, Güneş F, Demir O, Duygu F. Predictors of histological indication for treatment in HBeAg negative chronic HBV infection. J Med Virol 2017;89:1952-7. [PMID: 28618019 DOI: 10.1002/jmv.24879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
16 Arslan FD, Karakoyun I, Tatar B, Pala EE, Yıldırım M, Ulasoglu C, Duman C, Akar H, Kose S, Isbilen Basok B. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.63310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Madihi S, Syed H, Lazar F, Zyad A, Benani A. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries. Biomed Res Int 2020;2020:7027169. [PMID: 32626758 DOI: 10.1155/2020/7027169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Çetiner S, Çetin Duran A, Kibar F, Yaman A. Performance comparison of new generation HCV core antigen test versus HCV RNA test in management of hepatitis C virus infection. Transfus Apher Sci 2017;56:362-6. [PMID: 28342642 DOI: 10.1016/j.transci.2017.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Acikgoz A, Cimrin D, Kizildag S, Esen N, Balci P, Sayiner AA. Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study. BMC Infect Dis 2020;20:529. [PMID: 32698841 DOI: 10.1186/s12879-020-05247-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Coppola N, Alessio L, Gualdieri L, Pisaturo M, Sagnelli C, Minichini C, Di Caprio G, Starace M, Onorato L, Signoriello G, Macera M, Angelillo IF, Pasquale G, Sagnelli E. Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty. 2017;6:33. [PMID: 28179020 DOI: 10.1186/s40249-016-0228-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
21 Tosun S, Aygün O, Özdemir HÖ, Korkmaz E, Özdemir D. The impact of economic and social factors on the prevalence of hepatitis B in Turkey. BMC Public Health 2018;18:649. [PMID: 29789002 DOI: 10.1186/s12889-018-5575-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Cabalak M, Bal T, Onlen Y, Demir M. Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection. Trop Doct 2020;50:141-6. [PMID: 31810415 DOI: 10.1177/0049475519892082] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Köksal İ, Yılmaz G, Parlak M, Demirdal T, Kınıklı S, Candan M, Kaya A, Akhan S, Aydoğdu Ö, Turgut H, Gürbüz Y, Dağlı Ö, Gökal AA, Güner R, Kuruüzüm Z, Tarakçı H, Beslen N, Erdoğan S, Özdener F, Study Group TCHC. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study. Turk J Gastroenterol 2018;29:464-72. [PMID: 30249562 DOI: 10.5152/tjg.2018.16597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
24 Idilman R, Demir M, Aladag M, Erol C, Cavus B, Iliaz R, Koklu H, Cakaloglu Y, Sahin M, Ersoz G, Koksal İ, Karasu Z, Ozgenel M, Turan İ, Gunduz F, Ataseven H, Akdogan M, Kiyici M, Koksal AS, Akhan S, Gunsar F, Tabak F, Kaymakoglu S, Akarca US; Early Access Program (EAP) Study Groupa. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort. J Viral Hepat 2019;26:666-74. [PMID: 30740820 DOI: 10.1111/jvh.13075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Karacaer Z, Tosun S, Batırel A, Şahin S, Altaş İ, Uysal S, Erol S, Ceran N, Albayrak A, Yıldız İE, Kostakoğlu U, Kaçar F, Kuzhan N, Kadanalı A, Karagöz G, Yenilmez E, Bayırlı Turan D, Altunçekiç Yıldırım A, Koçak F, Çetinkaya RA, Parlak M, Aydın Ö, Ergen P, Durmuş G, Öztürk Kaygusuz T, Dağlı Ö, Demir C, Yılmaz Karadağ F. Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study. Turk J Gastroenterol 2018;29:177-82. [PMID: 29749324 DOI: 10.5152/tjg.2018.17431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Guo Y, Gao P, Wang H, Wu J, Bai Q, Huang L, Li S, Lv M, Shi X. Risk factors of hepatitis B virus infection between vaccinated and unvaccinated groups among spouses in 2006 and 2014: a cross-sectional study in Beijing. Hum Vaccin Immunother 2020;16:148-57. [PMID: 31287778 DOI: 10.1080/21645515.2019.1640428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Kebudi R, Özdemir N. Changes in hepatitis B antibody status after chemotherapy in children with cancer. Pediatr Blood Cancer 2020;67:e28120. [PMID: 31876336 DOI: 10.1002/pbc.28120] [Reference Citation Analysis]
28 Okay M, Aslan T, Özdemir E, Üner A, Sağlam A, Güngör E, Uysal A, Alayvaz Aslan N, Yıldızhan E, Ağıt A, Dal MS, Korkmaz S, Namdaroğlu S, Sivgin S, Akgün Çağlıyan G, Demircioğlu S, Barışta İ, Özhamam E, Vural F, Eser B, Özet G, Yıldırım R, Doğu MH, Berber İ, Erkurt MA, Malkan ÜY, Altuntaş F, Büyükaşık Y. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study. Turk J Haematol 2020;37:84-90. [PMID: 31630512 DOI: 10.4274/tjh.galenos.2019.2019.0177] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. J Hepatol. 2021;74:1200-1211. [PMID: 33484770 DOI: 10.1016/j.jhep.2021.01.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
30 Altuğlu I, Tanyeri S, Zeytinoğlu A, Altintoprak AE. HBsAg, Anti-HCV and Anti-HIV Seroprevalance Among Drug Users: a Retrospective Assessment. Noro Psikiyatr Ars 2019;56:186-90. [PMID: 31523144 DOI: 10.29399/npa.23505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Şahin AR, Erdoğan A, Gisi K, İspiroğlu M, Ateş S, Okyay RA, Nazik S, Kantarçeken B. Can family physicians have a role in eradication of hepatitis c infection? Turk J Gastroenterol 2020;31:393-9. [PMID: 32519959 DOI: 10.5152/tjg.2020.19913] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Çetin Duran A, Kaya Çetinkaya Ö, Sayıner AA, Şeydaoğlu G, Özkarataş E, Abacıoğlu H. Changes on Hepatitis C virus genotype distribution in Western Turkey: Evaluation of twelve-year data. Turk J Gastroenterol 2020;31:128-35. [PMID: 32141821 DOI: 10.5152/tjg.2020.18798] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Aygen B, Demir AM, Gümüş M, Karabay O, Kaymakoğlu S, Köksal AŞ, Köksal İ, Örmeci N, Tabak F. Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report. Turk J Gastroenterol 2018;29:259-69. [PMID: 29755010 DOI: 10.5152/tjg.2018.18263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
34 Alacam S, Karabulut N, Yolcu A, Onel M, Atasoy A, Kaymakoglu S, Agacfidan A. Evaluation of drug resistance mutations in patients with chronic hepatitis B. Folia Microbiol (Praha) 2019;64:237-43. [PMID: 30259350 DOI: 10.1007/s12223-018-0650-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Leblebicioglu H, Ozaras R. Hepatitis E virus infection in Turkey: a systematic review. Ann Clin Microbiol Antimicrob 2018;17:17. [PMID: 29716597 DOI: 10.1186/s12941-018-0269-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Balaban HY, Aslan AT, Ayar ŞN, Dağ O, Alp A, Şimşek C, Vahabov C, Yıldırım T, Göker H, Büyükaşık Y, Şimşek H. Lack of awareness of Hepatitis B screening and vaccination in high-risk groups. Turk J Med Sci 2021;51:1229-33. [PMID: 33433973 DOI: 10.3906/sag-2008-18] [Reference Citation Analysis]
37 Yamazhan T, Turan İ, Ersöz G, Günşar F, Pullukçu H, Danış N, Ünal NG, Vardar R, Oruç N, Tekin F, Taşbakan M, Sipahi OR, Akarca US. Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey. Turk J Gastroenterol 2020;31:239-45. [PMID: 32343236 DOI: 10.5152/tjg.2020.19076] [Reference Citation Analysis]
38 Bekçibaşı M, Arslan E. Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) /Hepatitis B virus (HBV) Co-infected Patients: A case series and review of the literature. Int J Clin Pract 2021;75:e14412. [PMID: 34051031 DOI: 10.1111/ijcp.14412] [Reference Citation Analysis]
39 Sayan M, Özgüler M, Sarıgül Yıldırım F, Yıldırmak T, Gündüz A, Dokuzoğuz B, Çelen MK, İnan D, Heper Y, Ersöz G, Karaoğlan İ, Ceran N, Deveci A, Öztürk S, Sayın Kutlu S, Özkan Özdemir H, Akbulut A, Yazıcı S, Şener A, Çağatay A, Ünal S. Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infections. Balkan Med J 2020;37:125-30. [PMID: 32106666 DOI: 10.4274/balkanmedj.galenos.2020.2019.5.89] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Akyıldız M, Ahıskalı E, Zeybel M, Yurdaydın C. Regional Epidemiology, Burden, and Management of Hepatitis B Virus in the Middle East. Clin Liver Dis (Hoboken) 2019;14:212-4. [PMID: 32015871 DOI: 10.1002/cld.887] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
41 Değertekin B, Demir M, Akarca US, Kani HT, Üçbilek E, Yıldırım E, Güzelbulut F, Balkan A, Vatansever S, Danış N, Demircan M, Soylu A, Yaras S, Kartal A, Kefeli A, Gündüz F, Yalçın K, Erarslan E, Aladağ M, Harputluoğlu M, Özakyol A, Temel T, Akarsu M, Sümer H, Akın M, Albayrak B, Sen İ, Alkım H, Uyanıkoğlu A, Irak K, Öztaşkın S, Uğurlu ÇB, Güneş Ş, Gürel S, Nuriyev K, İnci İ, Kaçar S, Dinçer D, Doğanay L, Göktürk HS, Mert A, Coşar AM, Dursun H, Atalay R, Akbulut S, Balkan Y, Koklu H, Şimşek H, Özdoğan O, Çoban M. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. Turk J Gastroenterol 2020;31:883-93. [PMID: 33626001 DOI: 10.5152/tjg.2020.20696] [Reference Citation Analysis]
42 Koc ÖM, Kremer C, Hens N, Bielen R, Busschots D, Van Damme P, Robaeys G. Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium. PLoS One 2020;15:e0234740. [PMID: 32716949 DOI: 10.1371/journal.pone.0234740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Babanejad M, Izadi N, Alavian SM. A Systematic Review and Meta-analysis on the Prevalence of HBsAg in Health Care Workers from Eastern Mediterranean and Middle Eastern Countries.Int J Prev Med. 2019;10:144. [PMID: 31516685 DOI: 10.4103/ijpvm.IJPVM_111_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Sargin Altunok E, Sayan M, Akhan S, Aygen B, Yildiz O, Tekin Koruk S, Mistik R, Demirturk N, Ural O, Kose Ş, Aynioglu A, Korkmaz F, Ersoz G, Tuna N, Ayaz C, Karakecili F, Keten D, Inan D, Yazici S, Koculu S, Yildirmak T. Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C. Int J Infect Dis 2016;50:1-5. [PMID: 27401586 DOI: 10.1016/j.ijid.2016.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
45 Karataylı E, Soydemir E, Aksoy ZB, Kızılpınar M, Altay Koçak A, Karataylı SC, Yurdcu E, Yıldırım U, Güriz H, Bozdayı G, Yurdaydın C, İlhan O, Yıldırım Y, Hdv Study Group MHGA, Bozdayı AM. Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016. Turk J Gastroenterol 2019;30:957-63. [PMID: 31767550 DOI: 10.5152/tjg.2019.18859] [Reference Citation Analysis]
46 Acikgoz A, Yoruk S, Kissal A, Yildirimcan Kadicesme Ş, Catal E, Kamaci G, Ersin F. Healthcare students' vaccination status, knowledge, and protective behaviors regarding hepatitis B: a cross-sectional study in Turkey. Hum Vaccin Immunother 2021;:1-8. [PMID: 34612171 DOI: 10.1080/21645515.2021.1973321] [Reference Citation Analysis]